Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...
Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...
After Labor limited the scope of his venue review and ignored his recommendation for a Victoria Park stadium, former Brisbane ...
A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...
Eli Lilly is developing a groundbreaking drug, lepodisiran, to combat high LPA cholesterol levels prevalent in South Asians, ...
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
The US Food and Drug Administration has approved fitusiran for bleeding prophylaxis in hemophilia A and B with or without ...
Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...
Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...
Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...
Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first antithrombin-lowering therapy in hemophilia, offers consistent ...
That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective at killing both gram-positive and gram-negative pathogenic bacteria, along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback